A detailed history of Quest Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Quest Partners LLC holds 7,992 shares of ABBV stock, worth $1.43 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
7,992
Previous 212 3669.81%
Holding current value
$1.43 Million
Previous $36.4 Million 4240.41%
% of portfolio
0.14%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$163.84 - $199.33 $1.27 Million - $1.55 Million
7,780 Added 3669.81%
7,992 $1.58 Billion
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $32,041 - $37,417
207 Added 4140.0%
212 $36.4 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $639 - $728
4 Added 400.0%
5 $911,000
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $137 - $154
1 New
1 $155,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.